Filing Details

Accession Number:
0001209191-20-046677
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-13 19:13:05
Reporting Period:
2020-08-11
Accepted Time:
2020-08-13 19:13:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326110 Nantkwest Inc. NK Biological Products, (No Disgnostic Substances) (2836) 431979754
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1424620 C John Thomas C/O Nantkwest, Inc.
3530 John Hopkins Court
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-11 19,790 $10.35 310,279 No 4 S Direct
Common Stock Disposition 2020-08-11 210 $10.55 310,069 No 4 S Direct
Common Stock Disposition 2020-08-13 20,000 $9.49 290,069 No 4 S Direct
Common Stock Disposition 2020-08-13 20,000 $9.34 270,069 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,886 Indirect See footnote
Footnotes
  1. Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person.
  2. Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.